Opening book details…
Can I read The experience of using the Brentuximab vedotin in the treatment of children and young adults with primary refractory course and relapses of Hodgkin's lymphoma on EtoBox?
The experience of using the Brentuximab vedotin in the treatment of children and young adults with primary refractory course and relapses of Hodgkin's lymphoma by M. N. Korsantya; Y. E. Romankova; N. V. Myakova; A. V. Pshonkin is a Medicine article available to read on EtoBox.
What is The experience of using the Brentuximab vedotin in the treatment of children and young adults with primary refractory course and relapses of Hodgkin's lymphoma about?
In many international studies, brentuximab vedotin (BV) has been shown to be highly effective in adult patients with primary refractory forms or recurrent Hodgkin’s lymphoma (HL). The group of children and adolescents received BV is not sufficient yet to assess the effectiveness and toxicity as in adults. In multicenter randomized trials BV was shown to be highly effective in adult patients. Aims: to evaluate the effectiveness and toxicity of anti-relapse therapy with BV followed by hematopoietic stem cell transplantation in children, adolescents and young adults with primary refractory forms of Hodgkin's Lymphoma (HL) and in patients with relapses of the disease. This study was approved by the Independent Ethical Committee and the Academic Council of Dmitriy Rogachev National Medical Research Center of Pediatric Hematology, Oncology, Immunology Ministry of Healthcare of Russian Federation. In the 2012–2019 period 54 patients with primary refractory course and relapses of LH (Hodgkin's Lymphoma) were enrolled, among them 24 (44.4%) boys and 30 (55.6%) girls aged 4 to 25 years at the time of diagnosis of HL (average age-13.84.4 years). Therapy included BV as a part of block BB (bren
Who reads The experience of using the Brentuximab vedotin in the treatment of children and young adults with primary refractory course and relapses of Hodgkin's lymphoma?
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- M. N. Korsantya; Y. E. Romankova; N. V. Myakova; A. V. Pshonkin
- Publisher
- Fund Doctors, Innovations, Science for Children
- Published
- 2020
- Language
- EN
- Field
- Medicine (Health Sciences)
More by M. N. Korsantya; Y. E. Romankova; N. V. Myakova; A. V. Pshonkin
Browse all works by M. N. Korsantya; Y. E. Romankova; N. V. Myakova; A. V. Pshonkin